idiopathic

InterMune Soaring 90% in Early Pre-Market on European Commit

agency, chmp, commission, committee, disease, drug, ema, esbriet, eu, european, fibrosis, human, idiopathic, intermune, ipf, itmn, lung, markets, medicinal, medicines, mild, products, pulmonary, treatment, use

InterMune (ITMN) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a marketing authorization for Esbriet (pi

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Autodesk Makes a Move: Up 2.1%...

Autodesk (NASDAQ:ADSK) is one of today's biggest movers, up 2.1% to $35.86. The Dow Jo ...

Alcatel-Lucent Up 5.3%, Shares Break Thr...

Alcatel-Lucent (NYSE:ALU) is one of today's best performing low-priced stocks, up 5.3% ...

Stock Investors Sell Off Shares of China...

China Telecom (NYSE:CHA) is one of today's notable stocks in decline, down 2.1% to $47. ...

Biodel Down 6.3%, Shares Slide into the ...

Biodel (NASDAQ:BIOD) is one of today's worst performing low-priced stocks, down 6.3% to ...

Stock Investors Bid Up Shares of Medicin...

Medicines Co (NASDAQ:MDCO) is one of today's biggest movers, up 2.1% to $33.21. The Do ...

Shares of Providence Service Under Press...

One of today's stocks on the move is Providence Service (NASDAQ:PRSC), down 2.2% to $27 ...

Zagg Shares Climbing Higher, Up 2.2%...

One of today's notable stocks on the rise is Zagg (NASDAQ:ZAGG), up 2.2% to $5.63. The ...

Stock Investors Sell Off Shares of Alere...

Alere (AMEX:ALR), a company whose shares are moving quickly, is trading 2.2% lower to $ ...

Most Popular Video News